RSC Advances
Paper
8H, 4CH2), 3.95–4.13 (m, 4H, 2CH2), 4.78 (s, 1H, CH), 6.75–6.79
(m, 2H, CH aromatic), 4.78 (s, 1H, CH), 6.75–6.79 (m, 2H, Ar),
7.00–7.04 (m, 2H, Ar), 7.20–7.25 (m, 2H, Ar), 7.84–7.88 (m, 2H,
Ar), 9.91 (s, 1H, COH) ppm. 13C NMR (DMSO, 75 MHz): d ¼ 20.3,
25.9, 27.1, 30.8, 37.0, 67.1, 67.9, 114.0, 114.7, 117.0, 117.1, 129.3,
129.8, 132.0, 136.8, 157.4, 163.7, 164.1, 190.9, 196.7 ppm. Mp
(ꢀC): 168–170.
9-(4-Chlorophenyl)-3,3,6,6-tetramethyl-3,4,5,6,7,9-hexahy-
dro-1H-xanthene-1,8(2H)-dione (Table 2, entry 7). 1H NMR
(DMSO, 300 MHz): d ¼ 1.25 (s, 6H, 2 ꢂ 2CH3), 2.19 (s, 2H, 2 ꢂ
CH2), 5.51 (s, 1H, CH), 7.11–7.17 (d, 2H,
2
ꢂ
2CH
aromatic) ppm. 13C NMR (DMSO, 75 MHz): d ¼ 26.9, 30.1, 36.0,
36.5, 52.4, 114.5, 128.4, 133.1, 141.3, 157.1, 198.7 ppm. Mp (ꢀC):
169–171.
4-(2-(4-(3,3,6,6-Tetramethyl-1,8-dioxo-2,3,4,5,6,7,8,9-octahy-
dro-1H-xanthene-9-yl)phenoxy)ethoxy)benzaldehyde (Table 2,
entry 13). H NMR (DMSO, 300 MHz): d ¼ 1.12 (s, 12H, 4CH3),
9-(2-Hydroxyphenyl)-3,3,6,6-tetramethyl-3,4,5,6,7,9-hexahy-
dro-1H-xanthene-1,8(2H)-dione (Table 2, entry 8). 1H NMR
(DMSO, 300 MHz): d ¼ 1.07 (s, 12H, 4CH3), 1.71 (s, 4H, 2CH2),
2.26 (s, 4H, 2CH2), 1.98–2.00 (m, 2H, CH2), 2.36 (s, 2H, CH2),
2.40 (s, 2H, CH2), 6.66–7.24 (m, 4H, CH-aromatic) 10.51 (s, 1H,
OH) ppm. 13C NMR (DMSO, 75 MHz): d ¼ 20.8, 27.7, 32.5, 34.2,
37.1, 48.5, 112.4, 115.7, 124.7, 126.2, 127.3, 128.8, 155.5, 157.9,
196.4 ppm. Mp (ꢀC): 200–202.
4-(3,3,6,6-Tetramethyl-1,8-dioxo-2,3,4,5,6,7,8,9-octahydro-
1H-xanthene-9-yl) benzaldehyde (Table 2, entry 9). 1H NMR
(DMSO, 300 MHz): d ¼ 1.25 (s, 6H, 2 ꢂ 2CH3), 1.88 (s, 2H, 2ꢂ
CH2), 2.19 (s, 2H, 2ꢂ CH2), 5.51 (s, 1H, CH), 7.11–7.17 (d, 2H, 2
ꢂ 2CH aromatic), 11.88 (s, 1H, COH) ppm. 13C NMR (DMSO, 75
MHz): d ¼ 28.3, 31.7, 37.8, 52.4, 115, 127.8, 130.2, 133.1, 149,
157.1, 195.6, 206.4 ppm. Mp (ꢀC): 295–297.
1
2.21 (s, 4H, 2CH2), 2.29 (s, 4H, 2CH2), 3.97 (s, 1H, CH), 4.29–4.32
(m, 2H, CH2), 4.37–4.40 (m, 2H, CH2), 6.79–6.86 (m, 4H,
aromatic), 7.04–7.07 (d, 2H, aromatic), 7.84–7.88 (m, 2H,
aromatic), 9.91 (s, 1H, COH) ppm. 13C NMR (DMSO, 75 MHz):
d ¼ 27.3, 32.2, 50.7, 66.0, 66.8, 114.1, 114.9, 115.6, 115.7, 127.8,
129.4, 132.0, 137.2, 156.8, 157.0, 162.1, 163.7, 190.8, 196.5 ppm.
Mp (ꢀC): 200–202.
2-(4-(2-(1,8-Dioxo-2,3,4,5,6,7,8,9-octahydro-1H-xanthene-9-
yl)phenoxy)butoxy)benzaldehyde (Table 2, entry 14). 1H NMR
(DMSO, 300 MHz): d ¼ 2.01–2.09 (m, 4H, 2CH2), 2.33–2.65 (m,
8H, 4CH2), 3.06–3.11 (m, 4H, 2CH2), 3.80 (s, 1H, CH), 3.97–4.14
(m, 4H, 2CH2), 6.94–7.04 (m, 3H, aromatic), 7.23–7.25 (d, 1H,
aromatic), 7.42–7.45 (d, 1H, aromatic), 7.57–7.60 (t, 1H,
aromatic), 7.69–7.71 (d, 1H, aromatic), 7.84–7.86 (d, 1H,
aromatic), 9.91 (s, 1H, COH) ppm. 13C NMR (DMSO, 75 MHz):
d ¼ 20.4, 25.9, 27.0, 30.3, 36.9, 67.7, 68.5, 112.5, 114.0, 119.8,
121.0, 124.7, 127.9, 131.0, 132.9, 136.9, 157.7, 158.6, 161.5,
189.5, 196.5. Mp (ꢀC): 220–222.
9,90-((Ethane-1,2-diylbis(oxy))bis(3,1-phenylene))bis(3,3,6,6-
tetramethyl-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione)
(Table 2, entry 15). 1H NMR (DMSO, 300 MHz): d ¼ 1.03 (s, 12H,
2 ꢂ 4CH3), 2.23 (s, 4H, 2 ꢂ 2CH2), 2.49 (s, 4H, 2 ꢂ 2CH2), 4.28
(s, 2H, 2ꢂ CH2), 4.77 (s, 1H, 2ꢂ CH), 6.70–7.18 (m, 4H, 2ꢂ
aromatic) ppm. 13C NMR (DMSO, 75 MHz): d ¼ 27.5, 32.2, 50.7,
112.4, 114.9, 115.5, 121.4, 128.9, 145.7, 158.5, 162.3, 196.4 ppm.
Mp (ꢀC): 250–252.
9-(1H-Indol-3-yl)-3,4,5,6,7,9-hexahydro-1H-xanthene-
1
1,8(2H)-dione (Table 2, entry 10). H NMR (DMSO, 300 MHz):
d ¼ 1.79–1.84 (m, 4H, 2CH2), 1.92–1.96 (m, 4H, 2CH2), 3.45–3.49
(t, 4H, 2CH2), 4.89 (s, 1H, CH), 6.93–6.98 (m, 2H, aromatic), 6.99
(s, 1H, CH indole), 7.04–7.59 (d of d, 2H, aromatic), 10.80 (s, 1H,
NH) ppm. 13C NMR (DMSO, 75 MHz): d ¼ 22.3, 26.9, 34.1, 36.9,
103.9, 111.8, 118.5, 119.4, 120.9, 124.2, 126.1, 136.6, 164.7,
196.8 ppm. Mp (ꢀC): 267–269.
3,3,6,6-Tetramethyl-9-(5-nitrofuran-2-yl)-3,4,5,6,7,9-hexahy-
dro-1H-xanthene-1,8(2H)-dione (Table 2, entry 11). 1H NMR
(DMSO, 300 MHz): d ¼ 1.14 (s, 12H, 4CH3), 1.85 (s, 4H, 2CH2),
2.32 (s, 4H, 2CH2), 5.47 (s, 1H, CH), 6.25 (s, 1H, furane), 7.28 (s,
1H, furane) ppm. 13C NMR (DMSO, 75 MHz): d ¼ 26.2, 28.0,
31.9, 35.5, 50.4, 110.3, 111.9, 115.1, 150.7, 161.5, 162.9,
196.1 ppm. Mp (ꢀC): 155–157.
4-(4-(4-(1,8-Dioxo-2,3,4,5,6,7,8,9-octahydro-1H-xanthene-9-
yl)phenoxy)butoxy)benzaldehyde (Table 2, entry 12). 1H NMR
(DMSO, 300 MHz): d ¼ 1.93–2.04 (m, 4H, 2CH2), 2.33–2.67 (m,
The general procedure of oxidation of alcohols
In a typical experiment, Fe3O4@NFC@NNSM-Mn(III) (0.5 mol%)
and TBHP (1 mmol) were placed in a vessel containing benzyl
Table 5 Comparison of the reaction conditions and results for the synthesis of xanthene
Entry
Catalyst
Solvent
Time (min)
Temp. (ꢀC)
Yield (%)
Ref.
1
2
3
4
5
6
7
8
[SO3H–Pyrazine–SO3H]Cl2
Fe3O4 nanoparticles
TCCAa
[Et3N–SO3H]Cl
LUS-Pr-SO3Hb
[Cmmim][BF4]
ICl3/SiO2
NP
Cu(II)/NP
—
Solvent free
Solvent free
Solvent free
Solvent free
Solvent free
Solvent free
Solvent free
EtOH
10
20
40
60
15
120
60
6.5 h
120
24 h
10
100
100
110
80
140
80
93
90
78
97
90
94
90
90
98
—
96
56
64
65
22
66
67
68
69
75
Reux
Reux
Reux
45
9
10
11
EtOH
EtOH
EtOH
70
71
Fe3O4@NFC@NNSM-Mn(III)
This work
a
Trichloroisocyanuric acid. b Propyl sulfonic acid functionalized LUS-1 (Laval University silica) (LUS-Pr-SO3H).
4352 | RSC Adv., 2021, 11, 4339–4355
© 2021 The Author(s). Published by the Royal Society of Chemistry